Title |
A patient with chronic sacroiliitis undiagnosed for three years after isotretinoin use
|
---|---|
Published in |
BMC Musculoskeletal Disorders, May 2020
|
DOI | 10.1186/s12891-020-03290-6 |
Pubmed ID | |
Authors |
Cevriye Mülkoğlu, Barış Nacır |
Abstract |
Isotretinoin (ISO) is a synthetic vitamin A derivative which has been used for treatment-resistant acne vulgaris. Although most musculoskeletal side effects of ISO are common, including myalgia, arthralgia, and back pain, sacroiliitis is one of the uncommon side effects. ISO-induced sacroiliitis usually completely resolves within a few months by the cessation of the drug. In this paper, we present a 26-year-old female patient with chronic sacroiliitis that was probably induced by ISO and not resolved by the discontinuation of the drug. In this patient, sacroiliitis was overlooked for three years. Therefore, ISO usage should be considered in the differential diagnosis of sacroiliitis and low back pain. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 16 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 2 | 13% |
Other | 2 | 13% |
Researcher | 2 | 13% |
Student > Doctoral Student | 1 | 6% |
Lecturer > Senior Lecturer | 1 | 6% |
Other | 2 | 13% |
Unknown | 6 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 4 | 25% |
Unspecified | 2 | 13% |
Business, Management and Accounting | 1 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Psychology | 1 | 6% |
Other | 1 | 6% |
Unknown | 6 | 38% |